Enoxaparin Sodium News
Enoxaparin Sodium currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Enoxaparin Sodium with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Inhixa is indicated for adults for: Prophylaxis of venous thromboembolism, particularly in patients undergoing orthopaedic, general or oncological surgery. Prophylaxis of venous thromboembolism in...
- Evidence level: L5
- Predicted indications (20):
- purpura fulminans (99.8%)
- pulmonary embolism (disease) (99.6%)
- thrombophilia due to protein C deficiency, autosomal recessive (99.6%)
- acquired purpura fulminans (99.0%)
- primary release disorder of platelets (98.9%)
- atypical hemolytic-uremic syndrome with thrombomodulin anomaly (98.6%)
- pseudo-von Willebrand disease (98.5%)
- Glanzmann thrombasthenia (98.3%)
- neuropathy, painful (98.3%)
- disseminated intravascular coagulation (97.5%)
- thrombotic thrombocytopenic purpura (96.7%)
- retinal telangiectasia (90.7%)
- arteriosclerotic retinopathy (89.8%)
- retinal microaneurysm (89.8%)
- vertebral artery occlusion (89.4%)
- fetal and neonatal alloimmune thrombocytopenia (87.3%)
- retinal artery occlusion (87.1%)
- Ledderhose disease (87.1%)
- hemorrhagic disorder due to a constitutional thrombocytopenia (86.6%)
- bleeding diathesis due to a collagen receptor defect (86.4%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.